Form D · Biotechnology
Pillar Biosciences, Inc.
Natick, MA · CIK 0001805809
Offering snapshot reported Mar 10, 2020 · SEC filing
- Reported sold
- $18M Offering amount: $32.4M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 24, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 10, 2020 | Initial | $18,029,999 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-362390
Source: Form D, filed Mar 10, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shawn Liu | Director |
| Hong Fang Sang | Director |
| Gang Song | Director, Executive |
| Zhaohui Wang | Director |
| Hui Yang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12 Michigan Dr.
Natick, MA, 01760
Natick, MA, 01760